<DOC>
	<DOC>NCT02211170</DOC>
	<brief_summary>Study to determine the effect of a single dose BIRB 796 BS on systemic inflammatory responses induced by endotoxin in healthy humans</brief_summary>
	<brief_title>Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subjects as determined by results of screening Signed written informed consent in accordance with Good Clinical Practice and local legislation Age ≥18 and ≤ 35 years Broca ≥ 20 % and ≤ + 20% Able to communicate well with the investigator and to comply with study requirements Any finding of the medical examination (including blood pressure, pulse rate and EKG) deviating from normal and of clinical relevance Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Surgery of gastrointestinal tract (except appendectomy) Diseases of the central nervous system (such as epilepsy) or psychiatric disorders or neurological disorders History of orthostatic hypotension, fainting spells or blackouts Chronic or relevant acute infections within 14 days of enrolment History of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator Intake of drugs with a long halflife (&gt; 24 hours) (&lt; 1 month prior to administration or during the trial) Use of any drugs, which might influence the results of the trial (&lt; 10 days prior to administration or during the trial) Participation in another trial with an investigational drug (&lt; 3 months prior to administration or during trial) Smoker (&gt; 10 cigarettes or &gt;3 cigars or &gt;3 pipes/day) Inability to refrain from smoking on trial days Alcohol abuse (&gt; 60 g/day) Drug abuse Blood donation or loss &gt; 400 ml (&lt; 2 month prior to administration or during the trial) Excessive physical activities (&lt; 24 hours prior to administration or during the trial) Any laboratory value outside the reference range of clinical relevance History of any familial bleeding disorder Weight &gt; 150 kg Prior confirmed or suspected receipt of a monoclonal antibody</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>